APRICOT
Antithrombotics in the Prevention of Reocclusion In COronary Thrombolysis


Purpose
To assess the effect of aspirin or warfarin on reocclusion and recurrent ischaemia after thrombolysis

References
Meijer A, Verheugt FWA, Werter CJPJ, et al: Aspirin versus Coumadin in the prevention of reocclusion and recurrent ischemia after successful thrombolysis: a prospective placebo-controlled angiographic study. Results of the APRICOT study. Circulation 1993, 87:1524–1530.
Veen G, Meijer A, Verheugt FWA,
et al: Culprit lesion morphology and stenosis severity in the prediction of reocclusion after coronary thrombolysis: angiographic results of the APRICOT study. J Am Coll Cardiol 1993, 22:1755–1762.
Meijer A, Verheugt FWA, Van Eenige MJ,
et al: Left ventricular function at 3 months after successful thrombolysis: impact of reocclusion without reinfarction on ejection fraction, regional function, and remodeling. Circulation 1994, 90:1706–1714.

Voltar

Apoio: Libbs Farmacêutica Farmacêutica